Pulmonary Fibrotic Diseases This review covers fibrotic pulmonary diseases. Although
idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases …

Although these conditions are rare, a proportion of patients with interstitial lung diseases
(ILDs) may develop a progressive-fibrosing phenotype. Progressive fibrosis is associated …

Objectives To compare mortality risks in patients with rheumatoid arthritis-associated
interstitial lung disease (RA-ILD) and patients with RA without ILD. Design Matched cohort …

Background Idiopathic interstitial pneumonias are often complicated by pulmonary
hypertension, increasing morbidity and mortality. There are no approved treatments for …

Introduction Interstitial lung disease (ILD) is a frequent manifestation of connective tissue
disease (CTD) with substantial variability in prevalence and outcomes reported across CTD …

The availability of epidemiological data relating to interstitial lung diseases (ILDs) has
increased over recent years, but information on the prevalence and incidence of ILDs of …

Objective The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-
19) have not been reported. This study aimed to describe the clinical features of COVID-19 …

Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …

Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …

Objective Interstitial lung disease (ILD) is one of the most serious complications of
rheumatoid arthritis (RA). In the present study, we aimed to assess the efficacy of abatacept …